My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 292

    1.

    Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.

    McCarter RJ, Hempe JM, Gomez R, Chalew SA.

    Diabetes Care. 2004 Jun;27(6):1259-64.PMID: 15161772 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hemoglobin Glycosylation Index is not related with blood glucose.

    Merino-Torres JF, Fajardo-Montañana C, Ferrer-García JC, Piñón-Sellés F.

    J Diabetes Complications. 2003 Sep-Oct;17(5):249-53.PMID: 12954152 [PubMed - indexed for MEDLINE]Related articles

    3.

    Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.

    Zhang L, Krzentowski G, Albert A, Lefebvre PJ.

    Diabetes Care. 2001 Jul;24(7):1275-9.PMID: 11423515 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    5.

    The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

    [No authors listed]

    Diabetes. 1995 Aug;44(8):968-83.PMID: 7622004 [PubMed - indexed for MEDLINE]Related articles

    6.

    Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.

    Kilpatrick ES, Rigby AS, Goode K, Atkin SL.

    Diabetologia. 2007 Dec;50(12):2553-61. Epub 2007 Sep 19.PMID: 17882397 [PubMed - indexed for MEDLINE]Related articles

    7.

    The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes. 1996 Oct;45(10):1289-98.PMID: 8826962 [PubMed - indexed for MEDLINE]Related articles

    8.

    Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.

    Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J.

    Pediatr Diabetes. 2009 May;10(3):168-76. Epub 2008 Oct 22.PMID: 19175900 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    JAMA. 2002 May 15;287(19):2563-9.PMID: 12020338 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial.

    McCarter RJ, Hempe JM, Chalew SA.

    Diabetes Care. 2006 Feb;29(2):352-5.PMID: 16443886 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

    [No authors listed]

    Diabetes. 1997 Nov;46(11):1829-39.PMID: 9356033 [PubMed - indexed for MEDLINE]Related articles

    12.

    Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden.

    Svensson M, Eriksson JW, Dahlquist G.

    Diabetes Care. 2004 Apr;27(4):955-62.PMID: 15047655 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial.

    Lachin JM, Genuth S, Nathan DM, Rutledge BN.

    Diabetes. 2007 Jul;56(7):1913-21. Epub 2007 Mar 14.PMID: 17360979 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    [No authors listed]

    N Engl J Med. 2000 Feb 10;342(6):381-9. Erratum in: N Engl J Med 2000 May 4;342(18):1376. PMID: 10666428 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.

    Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood.

    J Diabetes Complications. 2004 May-Jun;18(3):160-4.PMID: 15145327 [PubMed - indexed for MEDLINE]Related articles

    16.

    Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.

    Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A.

    Diabet Med. 2008 Feb;25(2):174-8.PMID: 18290858 [PubMed - indexed for MEDLINE]Related articles

    17.

    Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.

    Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM; DCCT Skin Collagen Ancillary Study Group.

    Diabetes. 2005 Nov;54(11):3103-11.PMID: 16249432 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.

    Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA.

    J Diabetes Complications. 2002 Sep-Oct;16(5):313-20.PMID: 12200073 [PubMed - indexed for MEDLINE]Related articles

    19.

    Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control.

    Kilpatrick ES, Rigby AS, Atkin SL.

    Clin Chem. 2007 May;53(5):897-901. Epub 2007 Mar 23.PMID: 17384010 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes.

    Chalew SA, McCarter RJ, Thomas J, Thomson JL, Hempe JM.

    J Diabetes Complications. 2005 Jul-Aug;19(4):218-22.PMID: 15993356 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity